Bilyk Jurij R, Murchison Ann P, Leiby Benjamin T, Sergott Robert C, Eagle Ralph C, Needleman Laurence, Savino Peter J
Oculoplartic and Orbital Surgery Service, Wills Eye Hospital, Philadelphia PA (Drs. Bilyk, Murchison), Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA (Dr. Leiby), Neuro-Ophthalmology Service, Wills Eye Hospital, Philadelphia PA (Dr. Sergott), Ocular Pathology Service, Wills Eye Hospital, Philadelphia PA (Dr. Eagle), Department of Radiology, Thomas Jefferson University, Philadelphia, PA (Dr. Needleman), Shiley Eye Institute, University of California, San Diego, La Jolla, CA (Dr. Savino).
Trans Am Ophthalmol Soc. 2018 Jun 25;115:T9. eCollection 2017 Aug.
To evaluate the diagnostic yield and concordance of color duplex ultrasound (CDU) of the superficial temporal artery (STA), temporal artery biopsy (TAB), and American College of Rheumatology (ACR) criteria in the diagnosis of giant cell arteritis (GCA).
Prospective, masked study of all patients evaluated in one institution suspected of having GCA. All patients with a suspected diagnosis of GCA were admitted for pulsed intravenous corticosteroids. Patients underwent serologic work-up and ACR criteria were documented. All patients had a CDU and TAB performed within 3 days of initiation of systemic corticosteroid therapy. Main outcome measure: Concordance of CDU and TAB. Secondary outcome measures: Concordance between unilateral and bilateral CDU and TAB by side and segment, concordance between TAB and ACR criteria, and statistical analysis of serologic markers for GCA.
The diagnosis of biopsy-proven GCA was found in 14 of 71 (19.7%) patients. The sensitivity of CDU compared to the reference standard of TAB ranged between 5.1% and 30.8% depending on the signs studied on CDU and correlation of specific TAB parameters. Of the serologic studies, a platelet count threshold of 400,000μL had the highest positive (18.32) and lowest negative (0.37) likelihood ratios for a diagnosis of GCA.
In this study, CDU showed minimal value in diagnosing GCA compared to TAB. There was poor correlation between CDU results and ACR criteria for GCA. The threshold platelet count had higher positive and negative predictive values for GCA than CDU and is a useful serologic marker for GCA.
评估颞浅动脉彩色双功超声(CDU)、颞动脉活检(TAB)以及美国风湿病学会(ACR)标准在巨细胞动脉炎(GCA)诊断中的诊断率及一致性。
对某一机构中所有疑似患有GCA的患者进行前瞻性、盲法研究。所有疑似GCA诊断的患者均接受脉冲静脉注射皮质类固醇治疗。患者接受血清学检查并记录ACR标准。所有患者在开始全身皮质类固醇治疗的3天内进行CDU和TAB检查。主要观察指标:CDU与TAB的一致性。次要观察指标:单侧和双侧CDU与TAB在不同侧别和节段的一致性、TAB与ACR标准的一致性以及GCA血清学标志物的统计分析。
71例患者中有14例(19.7%)经活检证实为GCA。根据CDU检查的体征及特定TAB参数的相关性,与TAB参考标准相比,CDU的敏感性在5.1%至30.8%之间。在血清学研究中,血小板计数阈值为400,000μL时,诊断GCA的阳性似然比最高(18.32),阴性似然比最低(0.37)。
在本研究中,与TAB相比,CDU在诊断GCA方面价值极小。CDU结果与GCA的ACR标准之间相关性较差。血小板计数阈值对GCA的阳性和阴性预测价值高于CDU,是GCA的一个有用血清学标志物。